{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:28Z","timestamp":1760188528097},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1984,9,1]],"date-time":"1984-09-01T00:00:00Z","timestamp":462844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1984,9]]},"DOI":"10.1007\/bf01806487","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T03:28:29Z","timestamp":1119929309000},"page":"209-220","source":"Crossref","is-referenced-by-count":36,"title":["Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer"],"prefix":"10.1007","volume":"4","author":[{"given":"Jan G. M.","family":"Klijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank H.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinus A.","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roel","family":"Docter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Alexieva-Figusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Blonk","family":"van der Wijst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W. J.","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806487_CR1","first-page":"257","volume-title":"Vitamins and Hormones","author":"AV Schally","year":"1980","unstructured":"Schally AV, Arimura A, Coy DH: Recent approaches to fertility control based on derivatives of LH-RH.In Munson PL, Diczfalusy E, Glover J, Olson RE (eds): Vitamins and Hormones. Academic Press, New York, 1980, pp 257\u2013323"},{"key":"BF01806487_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0015-0282(16)43461-8","volume":"30","author":"J Sandow","year":"1978","unstructured":"Sandow J, Von Rechenberg W, Terzabek G, Stoll W: Pituitary gonadotropin inhibition by a highly active analog of luteinizing hormone-releasing hormone. Fertil Steril 30:205\u2013209, 1978","journal-title":"Fertil Steril"},{"key":"BF01806487_CR3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0014-2964(77)90005-6","volume":"13","author":"A Danguy","year":"1977","unstructured":"Danguy A, Legros N, Heuson-Stiennon JA, Pasteels JL, Atassi G, Heuson JC: Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on 7,12-dimethylbenz (a)anthracene-induced rat mammary tumours. Histological and endocrine studies. Eur J Cancer 13:1089\u20131094, 1977","journal-title":"Eur J Cancer"},{"key":"BF01806487_CR4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1210\/endo-108-5-1878","volume":"108","author":"SWJ Lamberts","year":"1981","unstructured":"Lamberts SWJ, Uitterlinden P, Zuiderwijk-Roest JM, Bons-van Evelingen EG, de Jong FH: Effects of a luteinizing hormone-releasing hormone analog and tamoxifen on the growth of an estrogen-induced prolactin-secreting rat pituitary tumor and its influence on pituitary gonadotropins. Endocrinology 108:1878\u20131884, 1981","journal-title":"Endocrinology"},{"key":"BF01806487_CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/jrf.0.0640529","volume":"64","author":"BJA Furr","year":"1982","unstructured":"Furr BJA, Nicholson RI: Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer. J Reprod Fertil 64:529\u2013539, 1982","journal-title":"J Reprod Fertil"},{"key":"BF01806487_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/acta.0.0940489","volume":"94","author":"J Sandow","year":"1980","unstructured":"Sandow J, Von Rechenberg W, Jerzabek G, Engelbart K, Kuhl H, Fraser H: Hypothalamic-pituitary-testicular function in rats after supraphysiological doses of a highly active LRH analogue (Buserelin). Acta Endocrinol 94:489\u2013497, 1980","journal-title":"Acta Endocrinol"},{"key":"BF01806487_CR7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0006-291X(80)91580-6","volume":"95","author":"E Pedroza","year":"1980","unstructured":"Pedroza E, Vilchez-Martinez JA, Coy DH, Arimura A, Schally AV: Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone. Biochem Biophys Res Commun 95:1056\u20131062, 1980","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01806487_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0024-3205(81)90369-6","volume":"28","author":"K Sundaram","year":"1981","unstructured":"Sundaram K, Cav Y-Q, Wang NS, Bardin CW, Rivier J, Vale W: Inhibition of the action of sex steroids by gonadotropin releasing hormone (GnRH) agonists: a new biological effect. Life Sci 28:83\u201388, 1981","journal-title":"Life Sci"},{"key":"BF01806487_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endo-110-1-1","volume":"110","author":"P Lecomte","year":"1982","unstructured":"Lecomte P, Wang N-G, Sundaram K, Rivier J, Vale W, Bardin CW: The anti-androgenic action of gonadotropin-releasing hormone and its agonists on the mouse kidney. Endocrinology 110:1\u20136, 1982","journal-title":"Endocrinology"},{"key":"BF01806487_CR10","first-page":"3830","volume":"36","author":"ER DeSombre","year":"1976","unstructured":"DeSombre ER, Johnson ES, White WF: Regression of rat mammary tumors affected by a gonadoliberin analog. Cancer Res 36:3830\u20133833, 1976","journal-title":"Cancer Res"},{"key":"BF01806487_CR11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/bjc.1979.50","volume":"39","author":"RI Nicholson","year":"1979","unstructured":"Nicholson RI, Maynard PV: Anti-tumour activity of I.C.I.-118630, a new potent luteinizing hormone-releasing hormone agonist. Br J Cancer 39:268\u2013273, 1979","journal-title":"Br J Cancer"},{"key":"BF01806487_CR12","first-page":"27","volume":"55","author":"A Corbin","year":"1982","unstructured":"Corbin A: From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents. Yale J Biol Med 55:27\u201347, 1982","journal-title":"Yale J Biol Med"},{"key":"BF01806487_CR13","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1073\/pnas.78.10.6509","volume":"78","author":"TW Redding","year":"1981","unstructured":"Redding TW, Schally AV: Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogues of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 78:6509\u20136512, 1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01806487_CR14","first-page":"444","volume":"22","author":"HA Harvey","year":"1981","unstructured":"Harvey HA, Lipton A, Santen RJ, Escher GL, Hardy MA, Glode LM, Segaloff A, Landau RL, Schneir H, Max DT: Phase II study of a gonadotropin-releasing hormone analogue (Leuprolide) in postmenopausal advanced breast cancer patients (Abstract C-436). Proc Am Assoc Cancer Res\/Am Soc Clin Oncol 22:444, 1981","journal-title":"Proc Am Assoc Cancer Res\/Am Soc Clin Oncol"},{"key":"BF01806487_CR15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(82)92339-X","volume":"1","author":"JGM Klijn","year":"1982","unstructured":"Klijn JGM, de Jong FH: Treatment with a luteinizing hormone-releasing hormone analogue (Buserelin) in premenopausal patients with metastatic breast cancer. Lancet 1:1213\u20131216, 1982","journal-title":"Lancet"},{"key":"BF01806487_CR16","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1073\/pnas.79.5.1658","volume":"79","author":"G Tolis","year":"1982","unstructured":"Tolis G, Ackman D, Stellos A, Menta A, Labrie F, Fazekas ATA, Comaru-Schally AM, Schally AV: Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. Proc Natl Acad Sci USA 79:1658\u20131662, 1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01806487_CR17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(82)92279-6","volume":"1","author":"V Borgmann","year":"1982","unstructured":"Borgmann V, Hardt W, Schmidt-Gollwitzer M, Adenauer H, Nagel R: Sustained suppression of testosterone production by the luteinizing hormone-releasing hormone agonist Buserelin in patients with advanced prostate carcinoma. Lancet 1:1097\u20131099, 1982","journal-title":"Lancet"},{"key":"BF01806487_CR18","first-page":"110","volume":"23","author":"LM Glode","year":"1982","unstructured":"Glode LM: Leuprolide therapy of advanced prostatic cancer (Abstract C-426). Proc Am Assoc Cancer Res\/Am Soc Clin Oncol 23:110, 1982","journal-title":"Proc Am Assoc Cancer Res\/Am Soc Clin Oncol"},{"key":"BF01806487_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0277-5379(84)90233-5","volume":"20","author":"JGM Klijn","year":"1984","unstructured":"Klijn JGM, de Jong FH, Lamberts SWJ, Blankenstein MA: LHRH-agonist treatment in metastatic prostate carcinoma. Eur J Cancer Clin Oncol 20:483\u2013493, 1984","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806487_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2265.1980.tb02719.x","volume":"12","author":"JGM Klijn","year":"1980","unstructured":"Klijn JGM, Lamberts SJW, de Jong FH, Docter R, van Dongen KJ, Birkenh\u00e4ger JC: The importance of pituitary tumour size in patients with hyperprolactinaemia in relation to hormonal variables and extrasellar extension of tumour. Clin Endocrinol 12:341\u2013355, 1980","journal-title":"Clin Endocrinol"},{"key":"BF01806487_CR21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0014-2964(80)90064-X","volume":"16","author":"EORTC Breast Cancer Cooperative Group","year":"1980","unstructured":"EORTC Breast Cancer Cooperative Group: Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16:1513\u20131516, 1980","journal-title":"Eur J Cancer"},{"key":"BF01806487_CR22","first-page":"339","volume-title":"Neuroendocrine Perspectives, vol 1","author":"J Sandow","year":"1982","unstructured":"Sandow J: Gonadotropic and antigonadotropic actions of LH-RH analogues.In M\u00fcller EE, Macleod RM (eds): Neuroendocrine Perspectives, vol 1. Elsevier, Amsterdam, 1982, pp 339\u2013395"},{"key":"BF01806487_CR23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/endo-108-3-887","volume":"108","author":"RN Clayton","year":"1981","unstructured":"Clayton RN, Catt KJ: Regulation of pituitary GnRH receptors by gonadal hormones. Endocrinology 108:887\u2013895, 1981","journal-title":"Endocrinology"},{"key":"BF01806487_CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.375393","volume":"204","author":"AJW Hsueh","year":"1979","unstructured":"Hsueh AJW, Erikson GF: Extrapituitary action of gonadotropin-releasing hormone: direct inhibition of ovarian steroidgenesis. Science 204:854\u2013855, 1979","journal-title":"Science"},{"key":"BF01806487_CR25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/282090a0","volume":"282","author":"RN Clayton","year":"1979","unstructured":"Clayton RN, Harwood JP, Catt KJ: Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production. Nature 282:90\u201391, 1979","journal-title":"Nature"},{"key":"BF01806487_CR26","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1073\/pnas.77.8.4459","volume":"77","author":"RN Clayton","year":"1980","unstructured":"Clayton RN, Katikineni M, Chan V, Dufau MC, Catt KJ: Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells. Proc Natl Acad Sci USA 77:4459\u20134463, 1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01806487_CR27","first-page":"171","volume-title":"Hormones and Cancer, vol 14","author":"PA Kelly","year":"1980","unstructured":"Kelly PA, Turcot-Lemay L, Cusan L, Seguin C, Labrie F, Djiane J: Control of prolactin receptors in normal and neoplastic tissue.In Iacobelli S, King RBJ, Lindner HR, Lippman ME (eds): Hormones and Cancer, vol 14. Raven Press, New York, 1980, pp 171\u2013183"},{"key":"BF01806487_CR28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.6274016","volume":"214","author":"M Knecht","year":"1981","unstructured":"Knecht M, Catt KJ: Gonadotropin-releasing hormone: regulation of adenosine 3\u2032-5\u2032-monophosphate in ovarian granulosa cells. Science 214:1346\u20131348, 1981","journal-title":"Science"},{"key":"BF01806487_CR29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/jrf.0.0640517","volume":"64","author":"RM Sharpe","year":"1982","unstructured":"Sharpe RM: Cellular aspects of the inhibitory actions of LHRH on the ovary and testis. J Reprod Fertil 64:517\u2013527, 1982","journal-title":"J Reprod Fertil"},{"key":"BF01806487_CR30","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/0024-3205(80)90494-4","volume":"27","author":"PBC Jones","year":"1980","unstructured":"Jones PBC, Conn PM, Marian J, Hsueh AJW: Binding of gonadotropin releasing hormone agonist to rat ovarian granulosa cells. Life Sci 27:2125\u20132132, 1980","journal-title":"Life Sci"},{"key":"BF01806487_CR31","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1210\/endo-110-5-1663","volume":"110","author":"PBC Jones","year":"1982","unstructured":"Jones PBC, Hsueh AJW: Regulation of ovarian 3\u03b2-hydroxysteroid dehydrogenase activity by gonadotropin-releasing hormone and follicle-stimulating hormone in cultured rat granulosa cells. Endocrinology 110:1663\u20131671, 1982","journal-title":"Endocrinology"},{"key":"BF01806487_CR32","first-page":"779","volume":"64","author":"A Manni","year":"1980","unstructured":"Manni A, Pearson OH: Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function. Cancer Treat Rep 64:779\u2013785, 1980","journal-title":"Cancer Treat Rep"},{"key":"BF01806487_CR33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2265.1978.tb02172.x","volume":"8","author":"BE Senior","year":"1978","unstructured":"Senior BE, Cawood ML, Oakey RE, McKiddie JM, Siddle DR: A comparison of the effects of clomiphene and tamoxifen treatment on the concentrations of oestradiol and progesterone in the peripheral plasma of infertile women. Clin Endocrinol 8:381\u2013389, 1978","journal-title":"Clin Endocrinol"},{"key":"BF01806487_CR34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI109475","volume":"64","author":"BM Sherman","year":"1979","unstructured":"Sherman BM, Chapler FK, Grickard K, Wycoff D: Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 64:398\u2013404, 1979","journal-title":"J Clin Invest"},{"key":"BF01806487_CR35","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/bmj.285.6347.990","volume":"285","author":"HM Fraser","year":"1982","unstructured":"Fraser HM: New prospects for luteinizing hormone releasing hormone as a contraceptive and therapeutic agent. Br Med J 285:990\u2013991, 1982","journal-title":"Br Med J"},{"key":"BF01806487_CR36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0010-7824(81)90104-9","volume":"23","author":"M Schmidt-Gollwitzer","year":"1981","unstructured":"Schmidt-Gollwitzer M, Hardt W, Schmidt-Gollwitzer K, Von der Ohe M, Nevinny-Stickel J: Influence of the LHRH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control? Contraception 23:187\u2013195, 1981","journal-title":"Contraception"},{"key":"BF01806487_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2265.1982.tb02638.x","volume":"17","author":"C Bergquist","year":"1982","unstructured":"Bergquist C, Nillius SJ, Wide L: Intranasal LHRH agonist treatment for inhibition of ovulation in women: clinical aspects. Clin Endocrinol 17:91\u201398, 1982","journal-title":"Clin Endocrinol"},{"key":"BF01806487_CR38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/1097-0142(19810315)47:6<1297::AID-CNCR2820470611>3.0.CO;2-D","volume":"47","author":"MC Galli","year":"1981","unstructured":"Galli MC, De Giovanni C, Nicoletti G, Grilli S, Nanni P, Prodi G, Gola G, Rocchetta R, Orlandi C: The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary. Cancer 47:1297\u20131302, 1981","journal-title":"Cancer"},{"key":"BF01806487_CR39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/299056a0","volume":"299","author":"RN Clayton","year":"1982","unstructured":"Clayton RN, Huhtaniemi IT: Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature 299:56\u201359, 1982","journal-title":"Nature"},{"key":"BF01806487_CR40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1210\/jcem-54-5-1078","volume":"54","author":"RW Tureck","year":"1982","unstructured":"Tureck RW, Mastroianni L, Blasco L, Strauss JF: Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 54:1078\u20131080, 1982","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806487_CR41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(16)46105-4","volume":"37","author":"RF Casper","year":"1982","unstructured":"Casper RF, Erikson GF, Rebar RW, Yen SSC: The effect of luteinizing hormone-releasing factor and its agonist on cultured human granulosa cells. Fertil Steril 37:406\u2013409, 1982","journal-title":"Fertil Steril"},{"key":"BF01806487_CR42","doi-asserted-by":"crossref","unstructured":"Blankenstein MA, Henkelman MS, Klijn JGM: An analogue of LHRH antagonizes the growth-stimulating effect of oestradiol on human breast cancer cells in culture (MCF-7). J Steroid Biochem 19 (Suppl):95 S, 1983","DOI":"10.1016\/0022-4731(83)91786-7"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806487\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:48:55Z","timestamp":1586306935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1984,9]]}},"alternative-id":["BF01806487"],"URL":"https:\/\/doi.org\/10.1007\/bf01806487","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,9]]}}}